Effect of sirolimus on infection incidence in liver transplant recipients
Adrian Fisher, Joseph M. Seguel, Andrew N. de la Torre, Dorian Wilson, Anand Merchant, Rakesh K. Arora, Baburao Koneru – 30 January 2004 – Sirolimus is a new immunosuppressive agent that lacks the nephrotoxicity and neurotoxicity associated with calcineurin inhibitors.1–3 The addition of sirolimus to immunosuppressive protocols may thus allow sparing of calcineurin inhibitors and reduction or elimination of associated toxicities.1, 6 Between January 2000 and July 2001, sirolimus was administered to 55 of 116 consecutive liver recipients.